VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 234 filers reported holding VERACYTE INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $163 | +81.1% | 7,345 | +105.7% | 0.00% | – |
| Q2 2023 | $90 | +13.9% | 3,570 | 0.0% | 0.00% | – |
| Q1 2023 | $79 | -94.0% | 3,570 | -93.6% | 0.00% | -100.0% |
| Q4 2022 | $1,324 | -99.6% | 55,812 | +172.3% | 0.00% | – |
| Q3 2022 | $339,000 | +294.2% | 20,495 | +371.6% | 0.00% | – |
| Q2 2022 | $86,000 | -8.5% | 4,346 | +27.4% | 0.00% | – |
| Q1 2022 | $94,000 | -2.1% | 3,410 | +46.3% | 0.00% | – |
| Q4 2021 | $96,000 | +45.5% | 2,331 | +62.4% | 0.00% | – |
| Q3 2021 | $66,000 | -26.7% | 1,435 | -14.4% | 0.00% | – |
| Q1 2021 | $90,000 | +50.0% | 1,677 | +34.8% | 0.00% | – |
| Q4 2020 | $60,000 | -34.1% | 1,244 | -64.8% | 0.00% | – |
| Q2 2020 | $91,000 | +51.7% | 3,534 | +61.9% | 0.00% | – |
| Q4 2019 | $60,000 | +233.3% | 2,183 | +186.1% | 0.00% | – |
| Q3 2019 | $18,000 | – | 763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |